Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin powder in thoracolumbar fixation surgery
IRCT20260124068648N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jun 2024
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of vancomycin in degenerative spinal conditions and spondylolisthesis (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Pain severity and Bone fusion. Started Jun 2024; status: completed.
02
Drugs
vancomycin
03
Conditions
degenerative spinal conditionsspondylolisthesis
Beyond the preview
Go deeper on IRCT20260124068648N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260124068648N1.